1. Charcot–Leyden crystals and other protein crystals driving type 2 immunity and allergy. (October 2021) Authors: Aegerter, Helena; Smole, Ursula; Heyndrickx, Ines; Verstraete, Kenneth; Savvides, Savvas N; Hammad, Hamida; Lambrecht, Bart N Journal: Current opinion in immunology Issue: Volume 72(2021) Page Start: 72 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trial. Issue 12 (December 2021) Authors: Declercq, Jozefien; Van Damme, Karel F A; De Leeuw, Elisabeth; Maes, Bastiaan; Bosteels, Cedric; Tavernier, Simon J; De Buyser, Stefanie; Colman, Roos; Hites, Maya; Verschelden, Gil; Fivez, Tom; Moerman, Filip; Demedts, Ingel K; Dauby, Nicolas; De Schryver, Nicolas; Govaerts, Elke; Vandecasteele,... Journal: Lancet Issue: Volume 9:Issue 12(2021) Page Start: 1427 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The Charcot–Leyden crystal protein galectin‐10 is not a major determinant of human regulatory T‐cell function. Issue 9 (24th May 2022) Authors: Arroyo‐Hornero, Rebeca; Aegerter, Helena; Hamad, Ibrahim; Corte‐Real, Beatriz; Staes, Katrien; van der Woning, Bas; Verstraete, Kenneth; Savvides, Savvas N.; Lambrecht, Bart N.; Kleinewietfeld, Markus Journal: Allergy Issue: Volume 77:Issue 9(2022) Page Start: 2818 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗